Showing results (11-20 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|November 13, 2015
Balancing the risks and benefits of biologic therapy in inflammatory bowel diseasesItishree Trivedi, Stephen B HanauerExpert Opinion on Drug Safety|March 12, 2016
Anticholinergics: theoretical and clinical overviewPrasad S Nishtala, Mohammed Saji Salahudeen, Sarah N HilmerExpert Opinion on Drug Safety|March 12, 2016
A review of antidepressant-induced urinary hesitancy: a focus on levomilnacipran ER including two case presentations(5633)Gregory M Asnis, Elishka Caneva, Margaret A HendersonExpert Opinion on Drug Safety|May 24, 2012
Detection and management of nephrotoxicity during drug developmentMahmoud Loghman-Adham, Chek Ing Kiu Weber, Cornelia Ciorciaro, et al.Expert Opinion on Drug Safety|July 3, 2013
Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapiesGiuseppe Derosa, Arrigo Francesco Giuseppe Cicero, Anna Carbone, et al.Expert Opinion on Drug Safety|January 3, 2015
Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidenceEtienne Weisskopf, Céline J Fischer, Myriam Bickle Graz, et al.Expert Opinion on Drug Safety|December 31, 2014
Does hepatitis B virus therapy reduce the risk of hepatocellular carcinoma?Ezequiel RidruejoExpert Opinion on Drug Safety|January 6, 2015
Safety of inhaled corticosteroids for treating chronic obstructive pulmonary diseaseMaria Gabriella Matera, Vittorio Cardaci, Mario Cazzola, et al.Expert Opinion on Drug Safety|November 26, 2013
Basiliximab: efficacy and safety evaluation in kidney transplantationClaudio PonticelliExpert Opinion on Drug Safety|August 30, 2014
The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in ItalyCarla Carnovale, Tatiana Brusadelli, GianVincenzo Zuccotti, et al.Pageof 281